---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-102321"
form_type: "8-K"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2026-09-23T00:18:52+00:00"
generated_at: "2026-09-23T10:05:45.777503+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Apimeds completes 1-for-10 reverse stock split; share count falls to 1.51M

## Summary
- Reverse stock split effective 12:01 a.m. ET on July 24, 2026; every 10 shares combined into 1 share.
- Shares outstanding reduced from 15,091,180 to 1,509,118; 33,506 additional shares issued for fractional rounding.
- Par value reduced from $0.01 to $0.001 per share; authorized shares unchanged at 100M common, 10M preferred.
- Common stock trades on NYSE American under 'APUS' on split-adjusted basis; new CUSIP 03771D201.
- Proportionate adjustments made to outstanding equity awards and warrants and their exercise prices.

## SEC filing metadata
- accession: 0001213900-26-102321
- form_type: 8-K
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2026-09-23T00:18:52+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390026102321/0001213900-26-102321-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390026102321/ea0306326-8k_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-102321
- JSON: https://secwatch.observer/filing/0001213900-26-102321.json
- Plain text: https://secwatch.observer/filing/0001213900-26-102321.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.